Sun Pharma falls short of bond fundraising target amid rising yields
Sun Pharmaceutical secured new business.
· Economic Times Markets
Sun Pharma successfully secured ₹7,816 crore in its latest fundraising round, yet it fell short of its ambitious ₹10,000-crore target. The company opted for five- and seven-year bonds, pricing them at 8.05% and 8.20% respectively.
The analysis
Sun Pharmaceutical reported ₹7,816 crore, ₹10,000 and ₹2,100 crore, with movement of 8.05% and 8.20% attached to those lines. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Against that, the stock is +0.9% on the day at ₹1,777.70, and has returned -11.2% over three months. It sits 11% below its 52-week high. The pharma & healthcare sector has moved -0.9% over the same period, so Sun Pharmaceutical is running 10.3 points behind its peers.
For Sun Pharmaceutical, the question is how much of this is already reflected in the price and how much re-rates the pharma & healthcare peer set alongside it.
Market context
- In focus: Sun Pharmaceutical (SUNPHARMA), in Pharma & Healthcare.
- Over three months: Sun Pharmaceutical -11.2% against Pharma & Healthcare -0.9% (10.3 points behind).
- Trading well above normal today: Sun Pharmaceutical at 3.4 times its 20-day average volume.
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Sun PharmaceuticalSUNPHARMA · Pharma & Healthcare | ₹1,777.70 | +0.9% | -2.1% | -11.2% | -11.2% | 3.4× | — |
Pharma & Healthcare
1M -0.6% · 3M -0.9%
Sun Pharmaceutical
Prices as of 30 Oct 2026, 16:11 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Q2 Results Live: Varun Beverages Q3 Net Profit Rises 14% YoY; Reliance Slips, Sun Pharma Gains Ahead Of Earnings
Sun Pharma Q2 profit falls 36% as litigation costs hit earnings
Stocks To Watch Today: Dixon Tech, Syrma SGS, Sun Pharma, Wipro, Trent Among Others
Nifty Pharma index hits record high; Sun, Laurus, Zydus, Sai rally up to 6%
Acutaas Chemicals among 5 stocks hitting 52-week highs; rallied up to 18% in a month